KSKoji Sakuraya

Koji Sakuraya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Koji Sakuraya has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical practice guideline for pediatric IgA vasculitis in Japan 2023: a digest-secondary publication

    by Masaki Shimizu, Kandai Nozu, Koichi Kamei, Satoru Arai, Shinichi Ansai, Toru Igarashi, Takashi Ishige, Maki Urushihara, Toshiyuki Ohta, Masafumi Oka, et al.


  • CUBN variants in two children with asymptomatic proteinuria

    by Shunsuke Yokota, Kanako Saito, Haruhide Sakaguchi, Akina Matsuda, Koji Sakuraya, Hitohiko Murakami, Kandai Nozu, Shuichiro Fujinaga

    CUBN 遺伝子は近位尿細管においてアルブミンの再吸 収に関わる cubilin をコードしている 1) .近年,CUBN 遺 伝子異常に伴う慢性良性蛋白尿という疾患概念が提唱さ れ,その遺伝形式は常染色体潜性で,腎組織は微小変化 が多く,renin-angiotensin system(RAS)阻害薬は無効だが 腎予後良好といった特徴が報告されている 2) .今回,無 症候性蛋白尿を契機に CUBN 遺伝子異常による慢性良性 蛋白尿と診断した 2 例を経験したので過去の症例も加え て報告する. 症 例 症例 1:症例:6 歳男児 既往歴:3 歳時検尿で蛋白尿 家族歴:検尿異常や腎疾患なし 現病歴:X-3 年 5 月の 3 歳時検尿で蛋白尿の指摘あり 前医を紹介受診した.尿蛋白クレアチニン比(尿 TP/Cr) 0.8 g/gCr 程度が 3 か月持続したため当院紹介となり,X-3 年 12 月に腎生検目的で入院となった. 入院時現症:眼瞼浮腫なし,呼吸音清,腹部平坦・軟, 四肢の浮腫なし,紫斑なし 入院時検査所見(表 1) :尿検査では尿 TP/Cr 0.86 g/gCr と蛋白尿を認めたが,尿中β 2 ミクログロブリンの上昇や 血尿は認めなかった.血液検査では低アルブミン血症や 高コレステロール血症,腎機能障害を認めなかった.低 補体血症は認めず,抗核抗体,anti-neutrophil cytoplasmic antibody(ANCA) ,anti-glomerular basement membrane antibody(抗 GBM 抗体) ,hepatitis B surface antigen(HBs 抗 原) ,hepatitis C virus antibody(HCV 抗体)はすべて陰性 であった. 入院後経過:全身麻酔下で超音波ガイド下経皮的腎生 検を行った.糸球体は 15 個採取され光顕所見では微小 変化相当であった(図 1) .電顕所見では糸球体上皮細胞 に軽度の絨毛状変性がみられ,足突起の癒合を軽度認め た.腎生検後からアンジオテンシン受容体拮抗薬(ARB) を開始したが蛋白尿の改善が得られず(図 2) ,アンジオ テンシン変換酵素阻害薬(ACE-I)を追加してもやはり 改善がないため X-2 年 8 月に両親と児の遺伝学的検査 を行なったところ,CUBN 遺伝子に

  • Inhibition of renal fibrosis via Nrf2 activators for unilateral ureteral obstruction in a rat model

    by Hiroki Miyano, Amane Endo, Akira Mizutani, Mayu Nakagawa, Koji Sakuraya, Yayoi Murano, Naoto Nishizaki, Shuichiro Fujinaga, Yoshiyuki Ohtomo, Toshiaki Shimizu

    Background: Reactive oxygen species aggravate renal fibrosis, prompting the activation of nuclear factor erythroid 2‐related factor 2 (Nrf2), a key mediator in the cellular response to oxygen stress. Nrf2 exerts renoprotective effects by upregulating antioxidant response element (ARE)‐dependent genes that antagonize renal fibrosis. Elucidating mechanisms to attenuate renal fibrosis in children is essential for developing therapeutic interventions. This study aimed to examine the renoprotective effects of Nrf2 activators on ARE action in rats with unilateral ureteral obstruction (UUO)‐induced renal injury. Methods: The time course of Nrf2 was evaluated in 8‐week‐old male Sprague–Dawley rats with UUO, with or without Nrf2 activators (bardoxolone methyl) for 2 weeks postoperatively. Kidney tissues were collected on Days 7 and 14 post‐surgery. Renoprotective effects were examined using real‐time polymerase chain reaction (RT‐PCR) and histopathological analyses of kidney samples. Results: Nrf2 activators reduced the interstitial fibrotic area in UUO kidneys, causing a substantial decline in ED‐1‐positive cell infiltration and transforming growth factor‐β expression. RT‐PCR revealed that Nrf2 activators suppressed the expression of renal fibrotic factors and promoted the expression of ARE‐dependent genes. Moreover, immunostaining for Nrf2 demonstrated increased nuclear translocation and activation induced by Nrf2 activators. Conclusions: Nrf2 activators induced nuclear translocation and activation of Nrf2, resulting in upregulation of ARE‐dependent genes. Although the function of Nrf2 in children is often unknown, this study may lead to future progress in oxidation and antioxidant function in children.

  • Thrombotic thrombocytopenic purpura as initial presentation of systemic lupus erythematosus

    by Shota Endo, Shuichiro Fujinaga, Yoichi Takemasa, Yuta Oonuki, Koji Sakuraya


  • Open Access

    An extremely mild clinical course in a case with LAMB2-associated nephritis diagnosed with next-generation sequencing

    by Koji Sakuraya, Kandai Nozu, Hitohiko Murakami, China Nagano, Tomoko Horinouchi, Shuichiro Fujinaga, Kazumoto Iijima, Yoshiyuki Ohtomo

    Biallelic pathogenic variants in the laminin β2 (LAMB2) gene, which encodes laminin β2, are associated with Pierson syndrome characterized by a congenital nephrotic syndrome that rapidly progresses to end-stage renal disease, distinct ocular maldevelopment with bilateral microcoria, and neurodevelopmental deficits. However, the phenotypic spectrum of LAMB2-associated disorder is broader than expected, and cases with milder phenotypes such as isolated congenital or infantile nephrotic syndrome have also been reported. We report a patient with LAMB2-associated renal disorder showing an extremely mild phenotype. A 5-year-old girl presented with asymptomatic proteinuria and hematuria detected by urinalysis screening. She had been previously healthy without any additional renal symptoms. The serum albumin and creatinine levels were normal. Renal biopsy revealed minor glomerular abnormalities with occasional focal mesangial proliferation. Electron microscopy showed no structural changes in the glomerular basement membrane. Targeted sequencing of podocyte-related genes using next-generation sequencing was performed. As a result, previously reported biallelic pathogenic variants of the truncating variant (c.5073_5076dupCCAG) and a splice site variant (c.3797 + 5G > A) in the LAMB2 gene were detected, and the patient was diagnosed with LAMB2-associated renal disorder. Interestingly, a previously reported case with this splicing variant also showed an atypically mild phenotype. We suggest that clinicians should consider LAMB2-associated nephritis as an important differential diagnosis in children with asymptomatic proteinuria and microscopic hematuria if there is no structural change in the glomerular basement membrane. A comprehensive gene-screening system using next-generation sequencing is useful for diagnosing these atypical cases with isolated urine abnormalities.


  • A different clinical manifestation in a Japanese family with autosomal dominant distal renal tubular acidosis caused by SLC4A1 mutation

    by Koji Sakuraya, Kandai Nozu, Itsuhiro Oka, Shuichiro Fujinaga, China Nagano, Yoshiyuki Ohtomo, Kazumoto Iijima

    Mutations in SLC4A1, encoding the chloride–bicarbonate exchanger known as anion exchanger 1, have been reported as the sole genetic cause of autosomal dominant distal renal tubular acidosis (dRTA). This disorder is extremely rare and most patients show no clinical symptoms during childhood. Here, we report a case of an infant with early-onset autosomal dominant dRTA caused by SLC4A1 mutation p.Gly609Arg that is detected as a hot spot world widely. Despite the fact that the patient’s mother and sister had the same SLC4A1 mutation, all family members presented different clinical courses. A 9-month-old boy was referred to our hospital because of insufficient body weight gain. At the initial visit, his height and weight were 68.2 cm (−1.0 SD) and 6.4 kg (−2.2SD) respectively. Metabolic acidosis with a normal serum anion gap and inappropriate alkaline urine were detected. Abdominal ultrasound indicated bilateral renal medullary high-echoic lesions which suspected nephrocalcinosis. The genetic test revealed a heterozygous mutation c.1825G > A (p.Gly609Arg) in SLC4A1 that directed his diagnosis of autosomal dominant dRTA. The genetic test was performed on the patient’s family members, indicating that the same SLC4A1 mutation was detected in his mother and sister. His mother had nephrocalcinosis and metabolic acidosis at the age of 35 years. However, his sister had no clinical symptoms at the age of 6 years without any laboratory abnormalities. This familial case demonstrated that the significant heterogeneity in clinical manifestations may develop even among familial members sharing the same variant.